Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat and Melphalan in Relapsed/Refractory Multiple Myeloma
NCT00743288Phase 2Completed
- Sponsor
- ONCOtherapeutics
- Start
- Jul 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in multiple myeloma (MM), sponsored by ONCOtherapeutics. Started Jul 2008; status: completed.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00743288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743288.